• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT180
Device Problems Microbial Contamination of Device (2303); Failure to Clean Adequately (4048)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2024
Event Type  malfunction  
Manufacturer Narrative
The suspect device has been returned to olympus for evaluation and the investigation is ongoing.The physical device evaluation has been completed.Prior to the device evaluation, the device was sent out for additional microbiological testing.The hygiene microbiological investigation report indicated the forcep elevator channels and all channels of the scope were cultured and less than 1 cfu of any microbes were found.The results obtained comply with the target level for an endoscope subjected to high level disinfection and rinsed with sterile water.The device evaluation found that the nozzle was clogged with foreign material.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
It was reported that, during reprocessing, the ultrasound gastrovideoscope tested positive for microbiological contamination five times.On the first sampling, testing tested positive for 4 colony forming units (cfus) of micrococcus luteus, 4 cfus of staphylococcus capitis, and 1 cfu of staphylococcus warneri in all channels.On the second sampling, testing detected 7 cfu moraxella osloensis and 3 cfu micrococcus luteus in the forceps elevator wire channel.The third sampling, testing detected 1 cfu of staphylococcus epidermidis in all channels.In the fourth sampling, testing detected 2 cfu staphylococcus warneri, 1 cfu paenibacillus pabuli, and 2 cfu staphylococcus non aureuss in the forceps elevator wire channel.On the final sampling, testing detected 9 cfus of staphylococcus warneri in all channels.The user did not report any contamination or any other serious deterioration in state of health of any person, to which this medical device could have been a contributory cause.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacture's (lm) review of the customer cleaning disinfection and sterilization (cds) processes, results of third-party testing, the device evaluation and the lms final investigation.The lm reviewed the customer provided the cds processes where no obvious deviations from instructions for use (ifu) were identified.Olympus provided the following result of the culture test, performed at the third-party labs: culture examination results at the third-party organization: the parts where bacteria were detected: distal end of the channel.Total amount of detected bacteria: 3 cfu.Microbe name: bacillaceae (amount of bacteria: unknown).The device was evaluated where an additional potential adverse event was noted where foreign material remained clogging the nozzle.A review of the device history record found no deviations that could have caused or contributed to the reported issue.Based on the results of the investigation, it is likely bacteria were found due to improper reprocessing caused by the blocked nozzle however, the foreign material could not be identified nor the root cause of why it remained.Growth of microorganisms were found through culture testing by the user after reprocessing.However, when olympus culture tested after reprocessing in accordance with the ifu before repair, the results conformed to the regulation's recommendation.As a result of confirming the contents of the instruction manual of gf-uct180, reprocess method is described on the items below.Chapter 6 compatible reprocessing methods and chemical agents.Chapter 7 cleaning, disinfection, and sterilization procedures.Olympus will continue to monitor field performance for this device.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura
nishishirakawa-gun, fukushima 961-8 061
JA   961-8061
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18902001
MDR Text Key337859912
Report Number3002808148-2024-02405
Device Sequence Number1
Product Code ODG
UDI-Device Identifier04953170356346
UDI-Public04953170356346
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K093395
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberGF-UCT180
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/22/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/18/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Removal/Correction NumberZ-2818-2015
Patient Sequence Number1
-
-